ArticleCell death & disease2024

Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancer.

Valeria Canu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.